A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy.
Four color processed whole body bone scintigraphy with 99mTc-methylene diphosphonate was performed in six patients on maintenance hemodialysis, and the results of semiquantitative colorimetric analysis were compared with those of a normal group. The difference between the two (control and patient group) was statistically significant (P less than 0.01). Furthermore, the effect of 1 alpha-hydroxyvitamin D3 treatment on renal osteodystrophy was evaluated by this method. The results indicated that this method provides a useful method for assessing the response of renal osteodystrophy to treatment. Two representative cases of renal osteodystrophy are presented to illustrate the usefulness of this approach to semiquantitative whole body bone scanning.
D000328:Adult; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood / Q000000981:diagnostic imaging* / Q000628:therapy; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D006435:Renal Dialysis; D013382:Subtraction Technique / Q000295:instrumentation; D013667:Technetium; D013669:Technetium Tc 99m Medronate; D014915:Whole-Body Counting
D006887:Hydroxycholecalciferols; D013667:Technetium; C008088:alfacalcidol; D013669:Technetium Tc 99m Medronate